LIGAND PHARMACEUTICALS INC — Director's Dealing 2015

Feb 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-02-19

Reporting Person: Herman Melanie J (Director of Accounting)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-19	Common Stock	S	510.0	$57.84	Disposed	3521	Direct

Footnotes

F1: Shares sold to cover taxes on the vesting of restricted stock.